Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education
  • 4.9 (14)
  • COURSES
  • UPDATED SEMIWEEKLY

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

  1. HIV Update Podcast: Independent Conference Coverage of CROI 2026

    1D AGO

    HIV Update Podcast: Independent Conference Coverage of CROI 2026

    Tune into this podcast, featuring audio from a live conference coverage webinar, to learn from global experts, Monica Gandhi, MD, MPH, and Jean-Michel Molina, MD, as they summarize and discuss the latest updates on HIV treatment and prevention from CROI 2026. Topics covered include: Emerging HIV treatments Advances in HIV prevention Investigational agents for HIV prevention Early-phase investigational HIV treatments For more coverage of CROI 2026, and to follow along with the downloadable slides, visit the program page:https://bit.ly/4bmS062 Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Presenters: Monica Gandhi, MD, MPH Professor of Medicine and Associate Chief Division of HIV, Infectious Diseases, and Global Medicine Director, UCSF Center for AIDS Research (CFAR) Director of HIV Special Program "Ward 86" HIV Clinic San Francisco General Hospital San Francisco, California Jean-Michel Molina, MD Professor of Medicine Saint-Louis and Lariboisire Hospitals Université Paris Cité Paris, France   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    54 min
  2. Treatment of Refractory/Resistant CMV in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management

    5D AGO

    Treatment of Refractory/Resistant CMV in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management

    Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT), but there have been major advances in CMV management to date. In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID, and Marcus Pereira, MD, MPH, FAST, discuss considerations for CMV treatment in HCT recipients and examine treatment options for refractory/resistant CMV. Topics include: Considerations for CMV management in HCT recipients New definitions of refractory and resistant CMV  Risk factors for refractory and resistant CMV infections Identifying drug-resistant CMV  Treatment options for refractory/resistant CMV To view the full educational program and download the accompanying slides, visit our website:https://bit.ly/4lfrDTT Presenters: Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID Professor and Chair G.P. Bodey, Sr. Distinguished Professorship in Infectious Diseases President, The International Immunocompromised Host Society (ICHS) Director, Clinical Virology Research Department of ID/IC/EH UT MD Anderson Cancer Center Houston, Texas Marcus Pereira, MD, MPH, FAST Associate Professor of Medicine Director of Clinical Services, Division of Infectious Diseases Medical Director, Transplant Infectious Disease Program Columbia University Irving Medical Center New York, New York Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    25 min
  3. Managing CMV Risk in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management

    5D AGO

    Managing CMV Risk in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management

    Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID and Marcus Pereira, MD, MPH, FAST, discuss the burden of CMV in HCT recipients and explore strategies effectively identify and monitor high-risk patients. Topics include: Epidemiology of CMV among HCT recipients Direct and indirect effects of CMV after HCT Dynamics of risk factors for CMV infection  Strategies for prevention of CMV infection To view the full educational program and download the accompanying slides, visit our website:https://bit.ly/4lfrDTT Presenters: Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID Professor and Chair G.P. Bodey, Sr. Distinguished Professorship in Infectious Diseases President, The International Immunocompromised Host Society (ICHS) Director, Clinical Virology Research Department of ID/IC/EH UT MD Anderson Cancer Center Houston, Texas Marcus Pereira, MD, MPH, FAST Associate Professor of Medicine Director of Clinical Services, Division of Infectious Diseases Medical Director, Transplant Infectious Disease Program Columbia University Irving Medical Center New York, New York Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    15 min
  4. Shingles Solutions Podcast: Strategies for Improving Vaccine Uptake and Series Completion

    FEB 17

    Shingles Solutions Podcast: Strategies for Improving Vaccine Uptake and Series Completion

    In this podcast, experts Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH; Ruth Carrico, PhD, DNP, FNP-C, FAAN; and Dalilah Restrepo, MD, discuss improving shingles vaccine uptake. Topics covered include:  The Burden of ShinglesCare Coordination Between Primary and Specialty CarePromoting Shingles Vaccine Series CompletionAddressing Disparities in Shingles Vaccine Access and Uptake  Presenters: Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH Associate Professor of Clinical Pharmacy University of California, San Diego Department of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences Division of the Black Diaspora and African American Studies La Jolla, California Ruth Carrico, PhD, DNP, FNP-C, FAAN Senior Partner Carrico & Ramirez PLLC Professor, Adjunct Division of Infectious Diseases University of Louisville School of Medicine Louisville, Kentucky Dalilah Restrepo, MD Infectious Diseases Specialist University of California, Irvine Los Alamitos Hospital Orange County, California Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    29 min
  5. Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast

    FEB 3

    Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast

    Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help. Topics covered include: Mechanisms of pruritus and fatigue in PBCNonpharmacologic treatment optionsAn overview of clinical trial data supporting second-line agents for symptom management:BezafibrateElafibranorSeladelparInvestigational agents:VolixibatLinerixibatSetanaxibThis episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD,  MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    38 min
  6. Second-line Agents for Achieving Treatment Goals: Raising the Bar in PBC Management Podcast

    FEB 3

    Second-line Agents for Achieving Treatment Goals: Raising the Bar in PBC Management Podcast

    New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals. Topics covered include: Available agents for second-line treatment of PBCAn overview of clinical trial data supporting second-line agents:Obeticholic acid (OCA)BezafibrateElafibranorSeladelparThis episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    17 min
  7. Defining Our Treatment Goals: Raising the Bar in PBC Management Podcast

    FEB 3

    Defining Our Treatment Goals: Raising the Bar in PBC Management Podcast

    Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include: How and when to assess treatment responseRisk factors in PBCBiochemical treatment response and fibrosis stage as predictors of transplant-free survivalDynamics of liver stiffness measurements and clinical outcomes in PBCThe importance of bilirubin and alkaline phosphatase normalizationThis episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    18 min
  8. Keeping Up With New Developments in PBC

    FEB 2

    Keeping Up With New Developments in PBC

    Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice. Topics covered include:  Methods of Assessing PBC Disease ProgressionNewer Agents for Second-line Treatment of PBCPrioritizing Symptom Management and Quality of Life With PBC TreatmentPresenters: Christopher L. Bowlus, MD Lena Valenta Professor and Chief Division of Gastroenterology and Hepatology School of Medicine  University of California Davis  Sacramento, California Sonal Kumar, MD, MPH Assistant Professor of Medicine Division of Gastroenterology and Hepatology Weill Cornell Medical College New York, New York Link to full program:  https://bit.ly/43nHx6U Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    48 min
See All (493)

4.9
out of 5
14 Ratings

About

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

Information

You Might Also Like